Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 12 of about 12 for Merck & Co Inc�
Company Exchange Symbol Last price Quote change Market cap
Ligand Pharmaceuticals Inc. NASDAQ LGND 56.56 +1.89 (3.46%) 1.08B
Ligand Pharmaceuticals Incorporated (Ligand) is a biotechnology company that operates with a business model focused on developing or acquiring assets.
Merck & Co., Inc. NYSE MRK 62.82 +0.33 (0.53%) 178.26B
Merck & Co., Inc. is a health care company that offers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, ...
Enzon Pharmaceuticals Inc NASDAQ ENZN 0.980 0.000 (0.00%) 43.26M
Enzon Pharmaceuticals, Inc. (Enzon) is a biotechnology company. The Company's drug development programs utilize two platforms: Customized PEGylation Linker ...
Alkermes Plc NASDAQ ALKS 71.36 +1.55 (2.22%) 10.21B
Alkermes Public Limited Company is an integrated, global biopharmaceutical company. The Company has a portfolio of more than 20 commercial drug products and ...
Xenon Pharmaceuticals Inc NASDAQ XENE 19.44 -0.80 (-3.95%) 290.29M
(Teva) (through its subsidiary, Ivax International GmbH), Genentech, Inc. ( Genentech), and Merck & Co., Inc. (Merck) (through its affiliate, Essex Chemie ...
Nektar Therapeutics NASDAQ NKTR 14.75 +0.13 (0.89%) 1.88B
Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms.
MERCK AND CO INC EPA MRK 55.05 -0.02 (-0.04%)
XENON PHARMACEUTICALS FRA XP0 17.08 -0.76 (-4.25%)
ENZON PHARMACEUT. DL-,01 FRA EZ1 0.849 -0.025 (-2.86%)
ALKERMES PLC DL-,01 FRA 8AK 63.27 +0.06 (0.10%)
NEKTAR THERAPEUTICS FRA ITH 12.96 +0.16 (1.23%)
MERCK & CO INC CEDEAR (10 REP 1 USD0.50) BCBA MRK 0.0000